NASHUA, N.H., Sept. 19 iCAD, Inc.(Nasdaq: ICAD), an industry-leading provider of Computer-Aided Detection (CAD)solutions for the early identification of cancer, today announced that KenFerry, Chief Executive Officer, and Darlene Deptula-Hicks, Executive VicePresident and Chief Financial Officer of iCAD, will present a corporate updateat the UBS Global Life Sciences Conference on Wednesday, September 26th at1:00 p.m. (Eastern Daylight Time) at the Grand Hyatt New York.
The presentation will be webcast live and archived for replay on the"Investors" section of the company's Web site at http://www.icadmed.com.
About iCAD, Inc.
iCAD, Inc. (Nasdaq: ICAD) is an industry-leading provider of Computer-Aided Detection (CAD) solutions that enable healthcare professionals to betterserve patients by identifying pathologies and pinpointing cancer earlier. iCADoffers a comprehensive range of high-performance, upgradeable CAD systems forthe high, mid and low volume mammography markets. iCAD is entrusted with thetask of early cancer detection by over one thousand women's healthcare centersworldwide. For more information, call +1 877 iCADnow or visithttp://www.icadmed.com.
For iCAD, contact Darlene Deptula-Hicks, EVP and CFO at 603-882-5200 x7944or via email at [email protected]
For iCAD Investor Relations, contact Anne Marie Fields ofLippert/Heilshorn & Associates at 212-838-3777 x6604 or via email [email protected]
For iCAD Public Relations, contact Wendy Ryan of Schwartz Communicationsat 781-684-0770 or via email at [email protected]
SOURCE iCAD, Inc.